Larry W. Hardy

2.1k total citations
36 papers, 1.7k citations indexed

About

Larry W. Hardy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Materials Chemistry. According to data from OpenAlex, Larry W. Hardy has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Materials Chemistry. Recurrent topics in Larry W. Hardy's work include Biochemical and Molecular Research (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Enzyme Structure and Function (7 papers). Larry W. Hardy is often cited by papers focused on Biochemical and Molecular Research (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Enzyme Structure and Function (7 papers). Larry W. Hardy collaborates with scholars based in United States, United Kingdom and Germany. Larry W. Hardy's co-authors include Stephen M. Beverley, Bakela Nare, W.R. Montfort, Janet Finer-Moore, Robert M. Stroud, Daniel V. Santi, Jack F. Kirsch, James Luba, Frank Maley and Gladys F. Maley and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Larry W. Hardy

36 papers receiving 1.7k citations

Peers

Larry W. Hardy
Comparison fields: 5 of 100
  • Molecular Biology 1.2k
  • Public Health, Environmental and Occupational Health 446
  • Epidemiology 425
  • Materials Chemistry 328
  • Organic Chemistry 316
James R. Appleman United States
H. Eibl Germany
John G. Menting Australia
Claudia Kent United States
Jessica K. Holien Australia
Timothy E. Benson United States
Robert T. Jacobs United States
Wibke E. Diederich Germany
Subramanyam Swaminathan United States
Khalid Islam Italy
James R. Appleman United States View profile →
Citations per field, relative to Larry W. Hardy
Larry W. Hardy · 1×
Citations per year, relative to Larry W. Hardy
Larry W. Hardy · 1×

Countries citing papers authored by Larry W. Hardy

Since Specialization
Citations

This map shows the geographic impact of Larry W. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry W. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry W. Hardy more than expected).

Fields of papers citing papers by Larry W. Hardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry W. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry W. Hardy. The network helps show where Larry W. Hardy may publish in the future.

Co-authorship network of co-authors of Larry W. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Larry W. Hardy. A scholar is included among the top collaborators of Larry W. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry W. Hardy. Larry W. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo Biomedicine & Pharmacotherapy Rudy Schreiber, Una C. Campbell et al. 7
2 Functional deficit in hippocampal activity during fear extinction recall in the single prolonged-stress model of PTSD in male rats Behavioural Brain Research Larry W. Hardy, Jenna M. Sullivan et al. 5
3 Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects CNS Neuroscience & Therapeutics John J. Sramek, Larry W. Hardy et al. 3
4 Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor Bioorganic & Medicinal Chemistry Letters Liming Shao, Michael C. Hewitt et al. 7
5 Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors Bioorganic & Medicinal Chemistry Liming Shao, Fengjiang Wang et al. 16
6 Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor Bioorganic & Medicinal Chemistry Letters Liming Shao, Jianguo Ma et al. 3
7 Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor Design Journal of Molecular Biology Alexander W. Schüttelkopf, Larry W. Hardy et al. 65
8 Affinity Ligand Selection from a Library of Small Molecules: Assay Development, Screening, and Application Biotechnology Progress Lakshmi D. Saraswat, Larry W. Hardy et al. 6
9 The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets Drug Discovery Today Larry W. Hardy, Norton P. Peet 33
10 Crystallization of recombinant Leishmania major pteridine reductase 1 (PTR1) Acta Crystallographica Section D Biological Crystallography David G. Gourley, James Luba et al. 18
11 Alteration of T4 lysozyme structure by second‐site reversion of deleterious mutations Protein Science Anthony R. Poteete, Dale Rennell et al. 19
12 The Roles of Pteridine Reductase 1 and Dihydrofolate Reductase-Thymidylate Synthase in Pteridine Metabolism in the Protozoan Parasite Leishmania major Journal of Biological Chemistry Bakela Nare, Larry W. Hardy et al. 159
13 New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity Parasitology Bakela Nare, James Luba et al. 112
14 Reexamination of the role of Asp20 in catalysis by bacteriophage T4 lysozyme Biochemistry Larry W. Hardy, Anthony R. Poteete 49
15 Highly restricted distributions of hydrophobic and charged amino acids in longitudinal quadrants of alpha-helices. Journal of Biological Chemistry Rochelle R. Torgerson, R A Lew et al. 17
16 Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate Biochemistry W.R. Montfort, Kathy M. Perry et al. 202
17 Isolation of a Staphylococcus aureus β-lactamase-dicloxacillin complex and kinetic studies on the reactivation of the enzyme Archives of Biochemistry and Biophysics Larry W. Hardy, Jack F. Kirsch 6
18 Diffusion-limited component of reactions catalyzed by Bacillus cereus .beta.-lactamase I Biochemistry Larry W. Hardy, Jack F. Kirsch 65
19 Anomalous pH dependence of the reactions of carbenicillin and sulbenicillin with Bacillus cereus .beta.-lactamase I. Influence of the .alpha.-substituent charge on the kinetic parameters Biochemistry Larry W. Hardy, Jack F. Kirsch et al. 6
20 pH Dependence and solvent deuterium oxide kinetic isotope effects on Bacillus cereus .beta.-lactamase I catalyzed reactions Biochemistry Larry W. Hardy, Jack F. Kirsch 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026